WANTAI SARS-CoV-2 IgM ELISA Developing Scientifically Focusing on the Health For more information: [email protected] Add: 31 Kexueyuan Rd. changping, Beijing, China E-mail: [email protected] Sensitivity: 86.09% Specificity: 99.35% Incubation time: 30’+30’+15’ Specimen volume: 10μl

Clinical studies in China Prospective clinical evaluation was conducted at four hospitals in China during the 2020 COVID-19 outbreak. Samples from total of 572 cases were tested among which 266 were confirmed (China COVID-19 diagnosis protocol, including China CFDA approved PCR tests), and 306 were COVID-19 excluded cases. Clinical trial centers Academy of Military Medical Sciences Shenzhen Third People’s Hospital Zhejiang University Sensitivity and specificity of Wantai SARS-CoV-2 IgM ELISA Evaluation results Confirmed/ excluded SARS-CoV-2 results Sensitivity: 86.09% Specificity: 99.35% Overall...

Principle and Procedures Microwell strips pre-coated with anti-IgM capturing antibodies anti-IgM capturing antibodies Add 100μl of diluent and 10μl of specimens/ Controls Incubation at 37℃ for 30 min Add 50μl of Chromogen Solution A and 50μl of Chromogen Solution B Incubation at 37℃ for 15 min Read by single wavelength 450nm or dual wavelength 450/600~650nm Product WANTAI SARS-CoV-2 IgM ELISA Pack size HRP-conjugateded SARS-CoV-